Efficacy and tolerability of exenatide monotherapy over 24 weeks in antidiabetic drug—naive patients with type 2 diabetes: A randomized, double-blind, placebo-controlled, parallel-group study
Titel:
Efficacy and tolerability of exenatide monotherapy over 24 weeks in antidiabetic drug—naive patients with type 2 diabetes: A randomized, double-blind, placebo-controlled, parallel-group study
Auteur:
Moretto, Thomas J. Milton, Denái R. Ridge, Terry D. MacConell, Leigh A. Okerson, Ted Wolka, Anne M. Brodows, Robert G.